<DOC>
	<DOCNO>NCT00482482</DOCNO>
	<brief_summary>Major depression , chronic depression bipolar depression complex difficult disorder treat . They often associate residual symptom significant functional impairment . Yoga show beneficial treat depressive symptom without added risk associate medication use advantage high consumer appeal ( likelihood good compliance ) . However , test unipolar depression , thus far . Yoga show effective ( adjunctive pharmacotherapy ) improve residual symptom decrease risk relapse , would significant long-term benefit patient major chronic depression , also bipolar disorder . The aim study determine safety effectiveness Yoga augmentation treatment pharmacotherapy comparison psychoeducation , improve residual symptom depression 16 week prevention relapse/recurrence mood episode 1 year , subject unipolar bipolar disorder .</brief_summary>
	<brief_title>Yoga Unipolar Bipolar Disorders</brief_title>
	<detailed_description>Major depression ( particularly recurrent chronic depression ) bipolar depression remain complex vexing problem clinician . They difficult treat pharmacotherapy alone persistence residual symptom ( consequent impact function ) sub-syndromal symptom increase risk relapse . Psychotherapy alternative therapy explore adjunctive treatment pharmacotherapy show efficacy symptom relief . Complementary therapy , like herbal remedy yoga , also show efficacy , primarily unipolar depression . Yoga widely accept practice accessible adaptable different age range level physical ability . Yoga , show effective treatment major depression dysthymia randomize , control trial . To date , Yoga investigate subject bipolar disorder . We would like replicate current investigative result yoga depression Canadian sample unipolar chronic depression , would like extend literature investigate efficacy bipolar disorder . Could adjunctive Yoga treat sub-syndromal depressive symptom thus reduce risk relapse patient unipolar bipolar depression ? With high consumer desirability , general agreement need well-designed , randomize control trial examine efficacy safety intervention clinical population . This prospective , assessor-blind , crossover , randomize control study , carry three phase : 1 ) 16-week treatment phase , 2 ) 1 year follow-up phase . Forty patient meet DSM-IV-TR diagnostic criterion either Major Depression , Dysthymia , Bipolar I Bipolar II recruit . Patients provide write consent , meet study criterion , stabilize pharmacotherapy ( i.e . receive either one two mood stabilizer ( ) alone , combination oral atypical antipsychotic antidepressant lamotrigine ) enrol study . All patient receive treatment Yoga psychoeducation addition standard pharmacotherapy randomize one two treatment group group 1 ) 8 week yoga follow 8 week psychoeducation ; 2 ) 8 week psychoeducation follow 8 week Yoga . After completion treatment phase , 12-month follow-up phase . The specific hypothesis : 1 . At week 8 ( end first part treatment phase ) , treat Yoga plus pharmacotherapy would show decrease residual depressive symptom indicate great reduction MADRS score relative baseline increase quality life measure , compare treated psychoeducation plus pharmacotherapy . 2 . At week 16 ( end second part treatment phase ) , treat yoga plus pharmacotherapy would show decrease residual depressive symptom indicate great reduction MADRS score relative baseline increase quality life measure , compare treated psychoeducation plus pharmacotherapy.. 3 . Improvement depressive symptom correlate neuroendocrine change salivary cortisol .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Dysthymic Disorder</mesh_term>
	<criteria>Male female patient meet DSMIVTR diagnostic criterion either Major Depression , Dysthymia , Bipolar I Bipolar II disorder MADRS score ≥10 ≤24 YMRS score ≤8 Age 18 75 year Free significant physical illness evidence medical history , physical exam , routine clinical investigation clinically judge able tolerate physical activity Participants take prophylactic pharmacotherapy unipolar bipolar disorder stable dose minimum two week prior enrollment Participants currently Manic , Hypomanic , Mixed Phase Participants meeting DSMIVTR diagnostic criterion Rapid Cycling specifier History psychosis due Major Depression Bipolar Disorder , e.g . schizophrenia , schizoaffective disorder , etc . Alcohol Substance Abuse Dependence within past 3 month Participants currently receive systematic structured psychotherapy . Supportive therapy allow . Those major medical illness , physical impairment impact one ability participate study evidence medical history , physical exam , clinical investigation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Yoga</keyword>
	<keyword>Bipolar disorder</keyword>
	<keyword>Major depression</keyword>
	<keyword>Dysthymia</keyword>
	<keyword>Randomized</keyword>
</DOC>